NEW Optilift

OptiLIFT, a new device from Lumenis, is receiving positive reviews for its ability to address lower eyelid laxity and improve blinking in patients with dry eye disease. Clinical studies have shown significant improvements in tear breakup time, lid laxity, and blinking quality after treatment with OptiLIFT. Patients are also reporting positive aesthetic outcomes, such as a more youthful appearance. Strengthening the muscle around the eye improves the lifting support system of the midface, which can create a cascade effect that softens lower facial sagging and wrinkles.

One Treatment

Optilift offers a less invasive alternative to surgery for managing lower lid laxity.

Right side treated

Addresses lower and upper eyelid laxity and impaired blinking. It targets the muscles responsible for eyelid movement and blinking, improving their strength and function

Bottom treated

Optilift utilizes Lumenis' proprietary DMSt technology which delivers gentle electrical impulses to the muscles around the eyes. These impulses stimulate muscles.

Right side treated

Minimal downtime, most patients can return to their daily activity immediately after treatment.

1 treatment

Optilift does not effect melanin and is safe to be used on skin with more pigment.

This is after 4 treatments with Optilift and IPL for pigment and

rosacea. My upper lids are raised and look more symmetrical. I had Bell's palsy 6 years ago and my left side of my face dropped slightly. The overall skin looks more even and younger.

The typical treatment protocol for OptiLIFT involves four sessions, usually spaced out one to two weeks apart. Each session is relatively short, typically lasting 10-30 minutes. Some individuals will notice improvements after 3 sessions. To Maintain effects patients will need touch ups over time.